Ajinomoto Co Inc (2802)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Ajinomoto Co Inc (2802) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013429
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ajinomoto Co Inc (Ajinomoto) is a food products company that focuses on foods, bioscience fine chemicals and pharmaceuticals and health. It carries out research and development and production of seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. The company also provides solutions for improved food resources, human health and global sustainability. Ajinomoto is also involved in wellness, packaging, logistics, and other services. The company has operations in Europe, Africa, Japan, Asia and Americas. Ajinomoto is headquartered in Tokyo, Japan.

Ajinomoto Co Inc (2802) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ajinomoto Co Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ajinomoto Co Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ajinomoto Co Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ajinomoto Co Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Ajinomoto Co Inc, Medical Devices Deals, 2011 to YTD 2017 9
Ajinomoto Co Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Ajinomoto Co Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Eisai Forms Joint Venture with Ajinomoto 11
Althea Technologies Enters Into Co-Marketing Agreement With Sherpa Clinical 12
Licensing Agreements 13
Allena Pharma Amends Licensing Agreement With Althea Technologies 13
Ajinomoto North America Enters Into Licensing Agreement With Global Pharma Company For Corynex 14
Acquisition 15
Ajinomoto to Acquire GeneDesign 15
Ajinomoto Completes Acquisition Of Althea Technologies For US$175 Million 16
Ajinomoto Co Inc – Key Competitors 18
Ajinomoto Co Inc – Key Employees 19
Ajinomoto Co Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Joint Venture 23
Recent Developments 24
Other Significant Developments 24
Apr 13, 2017: Ajinomoto OmniChem Launches Flow Chemistry for API Commercial Manufacturing 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Ajinomoto Co Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Ajinomoto Co Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ajinomoto Co Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ajinomoto Co Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ajinomoto Co Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Ajinomoto Co Inc, Medical Devices Deals, 2011 to YTD 2017 9
Ajinomoto Co Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Eisai Forms Joint Venture with Ajinomoto 11
Althea Technologies Enters Into Co-Marketing Agreement With Sherpa Clinical 12
Allena Pharma Amends Licensing Agreement With Althea Technologies 13
Ajinomoto North America Enters Into Licensing Agreement With Global Pharma Company For Corynex 14
Ajinomoto to Acquire GeneDesign 15
Ajinomoto Completes Acquisition Of Althea Technologies For US$175 Million 16
Ajinomoto Co Inc, Key Competitors 18
Ajinomoto Co Inc, Key Employees 19
Ajinomoto Co Inc, Subsidiaries 21
Ajinomoto Co Inc, Joint Venture 23

★海外企業調査レポート[Ajinomoto Co Inc (2802)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Crown Holdings Inc:企業の戦略・SWOT・財務情報
    Crown Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Crown Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Noile-Immune Biotech Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Noile-Immune Biotech Inc (Noile-Immune Biotech) is a clinical stage biotechnology company that develops and commercializes next generation CAR-T cell therapies for the treatment of cancer. The company works in collaboration with National Cancer Center Japan and Yamaguchi University to develo …
  • Chorus Aviation Inc:企業の戦略・SWOT・財務情報
    Chorus Aviation Inc - Strategy, SWOT and Corporate Finance Report Summary Chorus Aviation Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Maharashtra State Power Generation Co Ltd-エネルギー分野:企業M&A・提携分析
    Summary Maharashtra State Power Generation Co., Ltd. (Mahagenco) is a state government-owned electricity company. The company generates and supplies electricity across the state of Maharashtra, India. Mahagenco owns and operates generation facilities, and uses diverse fuel sources such as thermal, g …
  • DKSH Holding Ltd. (DKSH):企業の財務・戦略的SWOT分析
    DKSH Holding Ltd. (DKSH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • The Lubrizol Corporation:企業の戦略・SWOT・財務情報
    The Lubrizol Corporation - Strategy, SWOT and Corporate Finance Report Summary The Lubrizol Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Sembcorp Industries Ltd (U96)-石油・ガス分野:企業M&A・提携分析
    Summary Sembcorp Industries Limited (Sembcorp) is a diversified energy, water and marine company. The company’s utilities division provides energy and water to industrial and municipal customers. Its energy operations include power generation, steam production and supply and natural gas import suppl …
  • Epsilon Energy Ltd (EPS):石油・ガス:M&Aディール及び事業提携情報
    Summary Epsilon Energy Ltd (Epsilon) is an oil and gas company that provides exploration, exploitation and development of oil and gas reserves. The company provides projects such as Marcellus shale in northeast Pennsylvania, Bakken Shale and Midale Dolomite in Saskatchewan, among others. It operates …
  • Guizhou Space Appliance Co., Ltd.:企業の戦略・SWOT・財務情報
    Guizhou Space Appliance Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Guizhou Space Appliance Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • VirnetX Holding Corp (VHC):企業の財務・戦略的SWOT分析
    Summary VirnetX Holding Corp (VirnetX) is a technology company that provides software and technology solutions for securing real-time communications. The company provides a gabriel connection technology which is an OEM software development kit, and is designed to secure real time communications over …
  • Beactica AB-製薬・医療分野:企業M&A・提携分析
    Summary Beactica AB (Beactica) is a drug discovery company that focuses on the development of novel therapeutics. The company offers wide range of services such as fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis and antibody interaction …
  • RHÖN-KLINIKUM AG:企業の戦略・SWOT・財務分析
    RHÖN-KLINIKUM AG - Strategy, SWOT and Corporate Finance Report Summary RHÖN-KLINIKUM AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Talon Metals Corp.
    Talon Metals Corp. - Strategy, SWOT and Corporate Finance Report Summary Talon Metals Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Visioneering Technologies Inc (VTI):企業の製品パイプライン分析
    Summary Visioneering Technologies Inc (VTI) is a medical device company that offers ophthalmic solutions. It develops a portfolio of technologies to address eye care issues such as presbyopia, myopia and astigmatism. Its technology includes myopia correction technology, silicone hydrogel material pl …
  • Alarko Contracting Group
    Alarko Contracting Group - Strategy, SWOT and Corporate Finance Report Summary Alarko Contracting Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Senju Pharmaceutical Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Senju Pharmaceutical Co Ltd (Senju) researches, develops, manufactures and markets pharmaceutical products for eye, ear, nose, throat, and skin. The company offers a wide range of ophthalmological products. Its product portfolio includes prescription products, OTC medicines and veterinary dr …
  • Kimco Realty Corporation (KIM):企業の財務・戦略的SWOT分析
    Kimco Realty Corporation (KIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • The Midcounties Co-operative:企業の戦略・SWOT・財務情報
    The Midcounties Co-operative - Strategy, SWOT and Corporate Finance Report Summary The Midcounties Co-operative - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • RPM International Inc:企業の戦略・SWOT・財務情報
    RPM International Inc - Strategy, SWOT and Corporate Finance Report Summary RPM International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Cardiovascular Systems Inc (CSII):企業の財務・戦略的SWOT分析
    Summary Cardiovascular Systems Inc (CSI) is a medical device company that develops and commercializes products for the treatment of peripheral and coronary vascular disease. The company's products include peripheral orbital atherectomy system, coronary orbital atherectomy system, crowns, and accesso …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆